Efficacy of meloxicam in a pain model in sheep

Objective To evaluate the efficacy of the non‐steroidal anti‐inflammatory drug, meloxicam, in alleviating pain and inflammation and on production‐related variables in a model of sterile acute inflammation in sheep. Methods Groups of 12 mature Merino ewes received 0, 0.5, 1.0 or 1.5 mg/kg meloxicam subcutaneously 90 min before injection of 0.1 mL turpentine subcutaneously on the anterior aspect of the proximal phalanx of a forelimb. Pain‐ and inflammation‐related variables were assessed at −18, 3, 6, 9, 12, 24, 48 and 72 h relative to meloxicam administration. Daily feed intake and body weight change 7 days later were also assessed. Pain‐related variables measured were weight borne on each forelimb, lameness score, time each forelimb was raised in a 20‐s interval and tolerance to a noxious mechanical stimulus. Inflammation‐related variables measured were skin temperature, limb circumference, body temperature, plasma haptoglobin concentration and peripheral blood leucocyte parameters. Results Meloxicam was effective in improving all pain‐related variables. A dose‐dependent response was seen between 0 and 1.0 mg/kg, with no additional benefit provided by 1.5 mg/kg. At a dose rate of 1.0 mg/kg, meloxicam improved weight borne on the turpentine‐treated limb by 14%, reduced the time the treated limb was held in a non‐weight‐bearing posture by 46%, reduced the lameness score by 58% and improved tolerance to pressure by 52%. No significant effects of meloxicam on inflammatory variables or appetite were observed. Conclusions Using a validated pain model, the data suggested that 1.0 mg/kg meloxicam provided significant analgesic benefits to sheep.